Douglas King,Partner with Wooden McLaughlin to Speak at TKG's Defective Drugs and Medical Devices: Understanding Mass Tort Litigation in the 2017 Landscape

Top Quote This event is scheduled for August 11, 2017 At 3:00 pm ET. End Quote
  • (1888PressRelease) August 09, 2017 - The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Douglas B. King, Partner with Wooden McLaughlin will speak at The Knowledge Group’s webcast entitled: “Defective Drugs and Medical Devices: Understanding Mass Tort Litigation in the 2017 Landscape.” This event is scheduled for August 11, 2017 from 3:00 pm to 4:30 pm ET.

    For further details, please visit:

    About Douglas B. King
    Douglas B. King is a partner at Indianapolis based Wooden & McLaughlin LLP. In his 40+ year civil litigation based practice, he has defended and tried numerous drug and medical device product liability cases. His trial and appellate work has yielded landmark cases and over thirty published decisions. Doug is a Fellow in the American College of Trial Lawyers, International Association of Defense Counsel and Litigation Counsel of America. Peer recognitions include 2003 Indiana Defense Lawyer of the Year; 2013-2016 "Best Lawyers in America" Mass Tort/Class Actions Defense; 2004-2017 Indiana Super Lawyers; Chambers USA 2017.

    About Wooden McLaughlin
    Founded in 1970, Wooden & McLaughlin LLP offers its clients a high level of experience, knowledge, accessibility and responsiveness. Before 1970, Bill Wooden and Robert McLaughlin were partners at another Indiana law firm. Because they were concerned that client responsiveness and attention would suffer if their firm became too large, they decided to form a new firm. Wooden & McLaughlin was formed with the idea that a law firm should strive to exceed commonly accepted standards of professionalism and client service while providing unsurpassed legal representation. The firm continues to build upon that tradition today.


    Pharmaceutical and medical device manufacturers, hospitals and healthcare providers increasingly find themselves in the crosshairs of mass tort litigation. Claims involving alleged defective drugs and medical devices are often surrounded by a multitude of complex issues, such as discovery and personal jurisdiction issues, which require a dsefense counsel's thorough knowledge and understanding.

    Our panel of key thought leaders and practitioners will provide an overview of the latest trends and developments in mass tort litigation involving defective drugs and medical devices. They will help the audience learn strategic approach in establishing defense in light of these trends and other complex issues that surround mass tort claims.

    Key topics include:
    -Steps to Take to Ensure Proportionality in Discovery
    -Utilizing Technology to Control the Data Instead of Letting the Data Control You
    -Effective Strategies for Identification and Retention of Expert Witnesses
    -Understanding and Addressing Regulatory Compliance Issue and Their Role in Litigation
    -How to Use the Quality System to Your Client’s Best Advantage
    -June 2017 Supreme Court opinion: Bristol-Myers Squibb v. Superior Court of California, No. 16-466
    -Case Background
    -The Decision
    -Practical Implications for Plaintiffs

    About The Knowledge Group/The Knowledge Congress Live Webcast Series
    The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit:

  • FB Icon Twitter Icon In-Icon
Contact Information